Bloomage BioTechnology Corp Ltd (shse:688363) Share Price

Company Profile

Business description
Bloomage BioTechnology Corp Ltd manufactures and sells a variety of chemicals and chemical-based products, typically made from hyaluronic acid sodium, or HA. The firm organizes itself into two segments based on product type. The HA raw materials segment, which generates the majority of revenue, sells HA and HA derivatives produced using bio-fermentation technology. The HA raw materials segment products are classified into three grades of HA: medicine grade, cosmetic grade, and food grade. The HA end products segment sells medical skin care products, bone products for intra-articular injection, and medical beauty devices. The majority of revenue comes from China.
Contact
No. 678 Tianchen Avenue
High-Tech Development Zone
Shandong Province
Jinan City
CHN
T: +86 1085670099
http://www.bloomagebio-tech.com
Sector
Basic Materials
Stock type
Cyclical
Industry
Specialty Chemicals
Fiscal Year End
31 December 2025
Employees
4,655

Recommended

The market is underestimating the clear path to profitability.

Roy van Keulen | 14 January 2025

Shares drop 17% after guidance is revised but we still see value.

Shane Ponraj | 09 January 2025

Australia's premier gas infrastructure firm used to be a market darling, but its shares have taken a severe de-rating in recent years.

Joseph Taylor | 09 January 2025

Index	Last price	Change	% Change
All Ordinaries	8,456.80	15.00	-0.18%
CAC 40	7,423.67	15.03	0.20%
DAX 40	20,271.33	138.48	0.69%
Dow JONES (US)	42,518.28	221.16	0.52%
FTSE 100	8,201.54	22.65	-0.28%
HKSE	19,260.17	40.39	0.21%
NASDAQ	19,044.39	43.71	-0.23%
Nikkei 225	38,444.58	29.72	-0.08%
NZX 50 Index	12,943.57	59.19	0.46%
S&P 500	5,842.91	6.69	0.11%
S&P/ASX 200	8,213.30	17.70	-0.22%
SSE Composite Index	3,227.12	13.82	-0.43%